WindRose Health Investors Acquires Ganse Apothecary and Integrates It with Terrapin Pharmacy
July 14, 2022
WindRose Health Investors completed the acquisition of Ganse Apothecary and merged it with Terrapin Pharmacy, an existing WindRose portfolio company, to create a behavioral health-focused pharmacy platform in the Mid-Atlantic. The combined business expands footprint and capabilities across Pennsylvania and surrounding states, serving approximately 7,500 patients across four states; terms were not disclosed.
- Buyers
- WindRose Health Investors, LLC, Terrapin Pharmacy
- Targets
- Ganse Apothecary
- Platforms
- Terrapin Pharmacy
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
WindRose Health Investors Recapitalizes Terrapin Pharmacy
January 5, 2022
Healthcare Services
WindRose Health Investors completed a recapitalization of Terrapin Pharmacy LLC, a closed-door specialty pharmacy serving behavioral health and long-term care populations in the Mid-Atlantic. The investment provides growth capital to support geographic expansion and increased market share; terms were not disclosed.
-
WindRose Health Investors Recapitalizes Traditions Behavioral Health
November 14, 2018
Healthcare Services
Funds managed by WindRose Health Investors completed a recapitalization of Traditions Behavioral Health (TBH), a West Coast provider of permanent outsourced physician psychiatric services. WindRose partnered with TBH's executive team (founder and CEO Gary A. Hayes remains in place) to provide growth capital to expand into new U.S. markets, broaden services and increase its network of psychiatrists.
-
WindRose Health Investors and Francisco Partners Invest in Avalon Healthcare Solutions
January 12, 2026
Healthcare Services
WindRose Health Investors has completed a growth investment in Avalon Healthcare Solutions, a Tampa-based diagnostic intelligence and lab benefits management platform. Existing investor Francisco Partners also made an additional investment to support Avalon’s continued product development and scaling for health plan clients.
-
WindRose Health Investors Invests in Stellus Rx
December 8, 2025
Healthcare Services
WindRose Health Investors has made a strategic growth investment in Stellus Rx, a Plano, Texas–based technology-enabled, value-based pharmacy care management platform. The undisclosed transaction will fund Stellus Rx’s expansion of clinical and operational capabilities and the scaling of its platform to serve additional patient populations nationwide.
-
WindRose Health Investors Recapitalizes Lykan Bioscience Holdings
June 4, 2019
Biotechnology
WindRose Health Investors completed an equity recapitalization of Lykan Bioscience Holdings, LLC, a Hopkinton, Massachusetts-based contract manufacturing services organization focused on cell and gene therapy production and logistics. The investment provides capital to support growth and the build-out of a 60,000+ square foot cGMP facility to expand manufacturing capacity; terms were not disclosed.
-
WindRose Health Investors Recapitalizes RevHealth
July 27, 2022
Healthcare Services
WindRose Health Investors completed a recapitalization of RevHealth, a Morristown, New Jersey-based omnichannel healthcare communications agency. The investment will provide capital to support RevHealth's growth and expansion of services; founders Bruce Epstein, Bruce Medd, and Brian Wheeler will continue to lead the company and remain significant shareholders.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.